Site 0288 - Minnesota Oncology Hematology - Maplewood — Maplewood, Minnesota

Site 0288 - Minnesota Oncology Hematology - Maplewood is a clinical research site located in Maplewood, Minnesota, United States 55109.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0288 - Minnesota Oncology Hematology - Maplewood has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Maplewood

Browse all research sites in Minnesota · View every site in Maplewood

• HealthEast St. John's Hospital
• Regions Hospital Sleep Center
• M Health Fairview St John's Hospital
• St John's Hospital
• HealthEast Cancer Care at St. John's Hospital
• Fairview Health Services M Health Fairview St Johns Hospital
• Saint John's Hospital-Healtheast
• Saint Johns Hospital
• St. John's Hospital Northeast/HealthEast, Inc.
• Minnesota Oncology Hematology PA-Maplewood
• Minnesota Oncology - Maplewood
• Minnesota Oncology Hematology, P.A

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0288 - Minnesota Oncology Hematology - Maplewood?

Site 0288 - Minnesota Oncology Hematology - Maplewood has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0288 - Minnesota Oncology Hematology - Maplewood conducted?

Site 0288 - Minnesota Oncology Hematology - Maplewood has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0288 - Minnesota Oncology Hematology - Maplewood accredited by Crixeo Clinical Trials?

Site 0288 - Minnesota Oncology Hematology - Maplewood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0288 - Minnesota Oncology Hematology - Maplewood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.